Lilly’s $3.5bn project heralds new life-sciences era for Lehigh Valley

Eli Lilly and Company has committed $3.5bn to build a major pharmaceutical manufacturing campus in Pennsylvania’s Lehigh Valley, marking the largest single economic development project in the region’s history and the biggest life-sciences investment the state has ever secured.

The Fortune 100 drugmaker will construct 925,000 sq. ft. of facilities at the Fogelsville Corporate Center in Upper Macungie Township and create 850 jobs over the next five years. The site will expand production of Lilly’s next-generation weight-loss medicines as demand for treatments such as Mounjaro and Zepbound continues to surge.

State backs project with $100m package

Pennsylvania Governor Josh Shapiro confirmed more than $100m in state support, including $50m in tax credits and grants totalling $50m for site development and project assistance. Shapiro said the commitment would “bring billions of dollars of investment and hundreds of good-paying jobs, solidifying our position as a leader in the growing life sciences industry.”

Lilly chief executive David Ricks told local and state officials that the expansion was driven by patient need. The company, which in December became the first drugmaker to reach a $1tn market valuation, is growing its US manufacturing network with additional facilities planned in Virginia, Texas and Alabama.

Building a talent pipeline

Lehigh Carbon Community College will receive further funding to develop specialist biotechnology and advanced-manufacturing programmes to support the workforce. Local economic leaders said the coordinated effort between state and regional partners had been critical to winning the project.

Don Cunningham, president and CEO of the Lehigh Valley Economic Development Corporation, described the announcement as the start of a new chapter for a region long defined by heavy industry. He said major pharmaceutical production would sit alongside existing employers such as B. Braun, Olympus and Thermo Fisher, strengthening a sector that has grown employment by 35 per cent over the past decade.

With 700 manufacturers already generating $9bn in annual GDP, Cunningham said the investment showed the Lehigh Valley continued to “punch above its weight class” as it transitions from its steelmaking heritage into the life-sciences age.